Bone marrow failure. By Zahraa Nasooh Al_Saaty

Similar documents
Aplastic anamia & Sideroblastic anemia

Year 2002 Paper two: Questions supplied by Jo 1

Outline. What is aplastic anemia? 9/19/2012. Aplastic Anemia Current Thinking on the Disease, Diagnosis, and Non-Transplant Treatment Options

Aplastic Anemia: Understanding your Disease and Treatment Options

APPROACHING TO PANCYTOPENIA

Bone marrow failure syndromes

The function of the bone marrow. Living with Aplastic Anemia. A Case Study - I. Hypocellular bone marrow failure 5/14/2018

Aplastic Anemia. is a bone marrow failure disease 9/19/2017. What you need to know about. The 4 major components of blood

Faculty of Medicine Dr. Tariq Aladily

Pediatrics. Aplastic Anemia in Children Prognosis and Survival Rate. Definition of Aplastic Anemia. See online here

INHERITED PANCYTOPENIA SYNDROMES Fanconi anemia Shwachman-Diamond syndrome Dyskeratosis congenita Congenital amegakaryocytic thrombocytopenia

Diseases Of The Blood

Overview of Aplastic Anemia. Overview of Aplastic Anemia. Epidemiology of aplastic anemia. Normal hematopoiesis 10/6/2017

Anemia (3).ms4.25.Oct.15 Hemolytic Anemia. Abdallah Abbadi

Aplastic Anemia Pathophysiology and Approach to Therapy

below the costal margin. The results of the main count showed a mild normocytic anaemia, with

Abnormal blood counts in children Dr Tina Biss Consultant Paediatric Haematologist Newcastle upon Tyne Hospitals NHS Foundation Trust

Constitutional Aplastic Anemias. Uma Kundu, M.D. July 17, 2006

Clinical & Laboratory Assessment

THE PATHOLOGY OF BONE MARROW FAILURE

QUESTIONS OF HEMATOLOGY AND THEIR ANSWERS

Bor-Sheng Ko. Hematology Division, Department of Internal Medicine, National Taiwan University Hospital

Study of diagnostic features of bone marrow in aplastic anaemia

Anemia (3).ms Hemolytic Anemia. Abdallah Abbadi Feras Fararjeh

Rory McCulloch. Specialty Trainee Haematology Royal Devon & Exeter Hospital

MDS 101. What is bone marrow? Myelodysplastic Syndrome: Let s build a definition. Dysplastic? Syndrome? 5/22/2014. What does bone marrow do?

7/13/2017. PreventionGenetics. How are genes associated with bone marrow failure?

UKGTN Testing Criteria

Contents SECTION 1: PHYSIOLOGY OF BLOOD

MYELODYSPLASTIC SYNDROMES

Year 2003 Paper two: Questions supplied by Tricia

PUO 1yr Hi Dr.Ashok kumar,

Borderline cytopenias. Dr Taku Sugai Consultant Haematologist

SESSION 1 Reactive cytopenia and dysplasia

MISCELLANEOUS DISORDERS

What is Anemia? Anemia means NOT ENOUGH RED BLOOD CELLS or LOWHEMOGLOBIN amount in the blood.

Pathology of Hematopoietic and Lymphoid tissue

Dairion Gatot, Soegiarto Ganie, Savita Handayani. Divisi Hematologi & Onkologi Medik Departemen Ilmu Penyakit Dalam FK-USU/RS H.Adam Malik Medan 2009

HEAMATOLOGICAL INDICES AND BONE MARROW BIOPSY

Hematopoietic Cell Transplantation in Bone Marrow Failure Syndromes

Heme 9 Myeloid neoplasms

Pathology of Hematopoietic and Lymphoid tissue

Introduction to Haematology. Prof Roger Pool Department of Haematology University of Pretoria

12 Dynamic Interactions between Hematopoietic Stem and Progenitor Cells and the Bone Marrow: Current Biology of Stem Cell Homing and Mobilization

Leukemias. Prof. Mutti Ullah Khan Head of Department Medical Unit-II Holy Family Hospital Rawalpindi Medical College

MDS: Who gets it and how is it diagnosed?

Myelodysplastic syndrome (MDS) & Myeloproliferative neoplasms

Diagnostic utility of bone marrow aspiration in pancytopenia

(anemia) ก hemoglobin concentration, hematocrit deviation 1 1 ก hemoglobin, hematocrit mean corpuscular volume (MCV) 2

Myelodysplastic Syndrome: Let s build a definition

9/9/2015 HISTORY & EPIDEMIOLOGY. Objectives. Textbook Definition of Aplastic anemia (AA) Epidemiology. History

Hematology Unit Lab 2 Review Material

MYELOPROLIFARATIVE NEOPLASMS. Dr. Hasan Fahmawi, MRCP(UK), FRCP(Edin).

MYELODYSPLASTIC SYNDROMES: A diagnosis often missed

The histopathology of bone marrow failure in children

Myeloid neoplasms. Early arrest in the blast cell or immature cell "we call it acute leukemia" Myoid neoplasm divided in to 3 major categories:

Aplastic Anemia: Current Thinking

Improved prognosis for acquired aplastic anaemia

MYELOPROLIFERATIVE DISEASE. Dr Mere Kende MBBS (UPNG), MMED (Path),MAACB, MACTM, MACRRM (Aus) Lecturer-SMHS UPNG

Disorders of Blood Cells & Blood Coagulation

Anaemia. The symptoms of anaemia are tiredness, shortness of breath and being pale. The anaemia in CDA is very variable.

Constitutional Hypoplastic Anemia

Bone Marrow Specimen (Aspirate and Trephine Biopsy) Proforma

CASE 106. Pancytopenia in the setting of marrow hypoplasia, a PNH clone, and a DNMT3A mutation

Chapter 11. Hyper IgM Syndromes

Epidemiology, Pathogenesis and Diagnosis of Aplastic Anaemia

Done By : WESSEN ADNAN BUTHAINAH AL-MASAEED

Myelodysplasia/Myeloproliferative Neoplasms (MDS/MPN) Post-HCT Data

Autoimmune lymphoproliferative syndrome (ALPS)

Acute Lymphoblastic Leukaemia

Evaluation of bone marrow aspirate in paediatric patients with pancytopenia: a 2 years study

Pathology. #11 Acute Leukemias. Farah Banyhany. Dr. Sohaib Al- Khatib 23/2/16

HAEMATOLOGICAL MALIGNANCY

Standard Therapies - Cord Blood

Acute Myeloid Leukemia: A Patient s Perspective

YEREVAN STATE MEDICAL UNIVERSITY DEPARTMENT OF HEMATOLOGY COURSE DESCRIPTION HEMATOLOGY

Case Workshop of Society for Hematopathology and European Association for Haematopathology

MORPHOLOGY OF BONE MARROW ASPIRATES. Dr.Prasanna N Kumar Head Department of Pathology, Oman Medical College, Oman

Hematology 101. Blanche P Alter, MD, MPH, FAAP Clinical Genetics Branch Division of Cancer Epidemiology and Genetics Bethesda, MD

DOWNLOAD PDF MACROCYTOSIS AND MACROCYTIC ANAEMIA

Evaluation of Anemia. Md. Shafiqul Bari Associate professor (Medicine) SOMC

There are two main causes of a low platelet count

Dana Alsulaibi. - Ahmad Almuhtaseb. - Tariq Al - Adaily

بسم هللا الرحمن الرحيم

APLASTIC ANEMIA: ACQUIRED AND INHERITED

Haemopoiesis. Matthew Hazell Consultant Clinical Scientist Trainee

Bone Marrow Transplantation for Fanconi Anaemia Using a Fludarabine-based Preparative Regimen with CD34+ Cell Selection

Dr. Rai Muhammad Asghar Associate Professor Head of Pediatric Department Rawalpindi Medical College

In adults, the predominant Hb (HbA) molecule has four chains: two α and two β chains. In thalassemias, the synthesis of either the α or the β chains

Normal Development. Normal Development 10/16/2012. Hematopoietic and Lymph Node Pathology. Red Blood Cell Maturation & Anemias

SYLLABUS ON HEMATOLOGY FOR THE 4-YEAR STUDENTS, MEDICINE-2. Total hours number 70 hours, including course 20 hours, seminars 50 hours.

Haemorrhagic Disorders. Dr. Bashar Department of Pathology Mosul Medical College

Session 11 Disorders of Red cells. B.M.C.Randika Wimalasiri Lecturer(Probationary) Department of Medical Laboratory Sciences

Evaluation of Bone Marrow Biopsies and Aspirates ANNA PORWIT DEPARTMENT OF PATHOLOGY, LUND UNIVERSITY

Classification of Anaemia

Advances in genetic studies of inherited bone marrow failure syndromes and their associated malignancies

July 3, The Physician Compare Team Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, MD 21244

r). SUPPLEMENTARY/SECOND OPPORTUNITY EXAMINATION PAPER nnmlbih UNIVERSITY Sophia Blaauw INSTRUCTIONS FACULTY OF HEALTH AND APPLIED SCIENCES

2013 AAIM Pathology Workshop

5/9/2018. Bone marrow failure diseases (aplastic anemia) can be cured by providing a source of new marrow

Transcription:

Bone marrow failure By Zahraa Nasooh Al_Saaty

Pancytopenia : Pancytopenia describes a reduction in the blood count of all the major cell lines-red cells,white cell and platelets. It has several causes which can be broadly divided into: decreased bone marrow production or increased peripheral destruction.

Aplastic (hypoplastic) anaemia: It is defined as pancytopenia resulting from aplasia of the bone marrow in the absence of an abnormal infiltrate and with no increase in reticulin. it is classified into: 1. primary: congenital or acquired. 2. secondary types.

Primary Congenital (Fanconi and non- Fanconi types) idiopathic acquired Secondary Ionizing radiation: accidental exposure (radiotherapy, radioactive isotopes, nuclear power stations) Chemicals: benzene, organophosphates and other organic solvents, DDT and other pesticides, organochlorines, recreational drugs (ecstasy) Drugs those that regularly cause marrow depression (e.g. busulfan, cyclophosphamide, anthracyclines, nitrosoureas) Those that occasionally or rarely cause marrow depression (e.g. chloramphenicol, sulphonamides, gold, anti-inflammatory, antithyroid, psychotrophic, anticonvulsant!antidepressant drugs) Viruses: viral hepatitis (non-a, non-b, non-c, non-g in most cases), EBV

Pathogenesis: The underlying defect in all cases appears to be a substantial reduction in the number of haemopoietic pluripotential stem cells, and a fault in the remaining stem cells or an immune reaction against them, which makes them unable to divide and differentiate sufficiently to populate the bone marrow.a primary fault in the marrow microenviromnent has also been suggested.

Congenital: The Fanconi type: It has an autosomal recessive pattern of inheritance and is often associated with: _ growth retardation _congenital defects: *of the skeleton (e.g. microcephaly, absent radii or thumbs) * of the renal tract (e.g. pelvic or horseshoe kidney) * or skin (areas of hyper- and hypopigmentation) _sometimes there is mental retardation. The encoded proteins of the affeected gene cooperate in a common cellular pathway involved in DNA repair so cells from Fanconi's anaemia (FA) patients show an abnormally high frequency of spontaneous chromosomal Breakage

The usual age of presentation of FA is 5-10 years. the diagnostic test is elevated breakage after incubation of peripheral blood lymphocytes with the DNA cross-linking agent diepoxybutane (DEB test). Approximately,10% of cases develop acute myeloid leukaemia.

Dyskeratosis congenita(dc): is a rare sex linked disorder with: _ nail and skin atrophy. _a high risk of cancer. it is associated with mutations in the: _ DKCl (dyskerin),or _TERC (telomerase reverse transcriptase RNA template) genes which are both involved in the maintenance of telomere length,so deficiency in stem cell activity due to defective telomerase activity. The demonstration of DKC1 and TERC mutations in DC families provides an accurate diagnostic test

Other inherited bone marrow failure syndromes: Diamond_Blackfan anemia (DBA) Shwachman_Diamond syndrome(sds) Sever congenital neutropenia Amegakaryocytic thrombocytopenia & thrombocytopenia with abscent radii. In DC,DBA & SDS there is a defect in ribosomal biosynthesis & function.

Idiopathic acquired: This is the most common type of aplastic anaemia,accounting for at least two-thirds of acquired cases.. In most cases haemopoetic tissue is the target of an immune process dominated by oligoclonal expression of cytotoxic T cells which secrete y-interferon and tumour necrosis factor. In approximately onethird of cases short telomeres are found in leucocytes, especially in those with a prolonged clinical course. Mutations in the telomere repair complex have been described but their relevance is unclear. The favourable responses to antilymphocyte globulin (ALG) and cyclosporine support the concept that autoimmune T-cell mediated damage, possibly against functionally and structurally altered stem cells.

Secondary: _This is often caused by: direct damage to the haemopoietic marrow by radiation or cytotoxic drugs. The antimetabolite drugs (e.g. methotrexate) and, mitotic inhibitors (e.g. daunorubicin) cause only temporary aplasia but the alkylating agents, particularly busulfan, may cause chronic aplasia closely resembling the chronic idiopathic disease. _Some individuals develop aplastic anaemia as a rare idiosyncratic side-effect of drugs such as chloramphenicol or gold which are not known to be cytotoxic. _Chemicals such as benzene may be implicated. _Rarely aplastic anaemia may be the presenting feature of acute lymphoblastic or myeloid leukaemia, especially in childhood. Myelodysplasia may also present with a hypoplastic marrow.

Clinical features: The onset is at any age with a peak incidence around 30 years and a slight male predominance; it can be insidious or acute with symptoms and signs resulting from anaemia, neutropenia or thrombocytopenia. _Infections, particularly of the mouth and throat, are common and generalized infections are frequently life-threatening. _ bruising, bleeding gums, epistaxes and menorrhagia are the most frequent haemorrhagic manifestations and the usual presenting features. _ symptoms of anaemia. _The lymph nodes, liver and spleen are not enlarged

Laboratory findings: 1. Anaemia is normochromic, normocytic or macrocytic (mean cell volume (MCV) often 95-110 fl). The reticulocyte count is usually extremely low in relation to the degree of anaemia. 2.Leucopenia. There is a selective fall in granulocytes usually but not always to below 1.5 x 109/L. In severe cases, the lymphocyte count is also low. 3.Thrombocytopenia is always present. 4.There are no abnormal cells in the peripheral blood. 5. The bone marrow shows hypoplasia, with loss of haemopoietic tissue and replacement by fat which comprises over 75% of the marrow. Trephine biopsy may show patchy cellular areas in a hypocellular background The main cells present are lymphocytes and plasma cells; megakaryocytes in particular are severely reduced or absent.

Severe cases show: neutrophils <0.5 x 109/L (very severe <0.2 x 109/L) platelets <20 x 109 reticulocytes <20 x 109/L and marrow cellularity <25%

Blood film

low power views of bone marrow show severe reduction of haemopoietic cells with an increase in fat spaces

Trephine biopsy

Differential diagnosis: Decreased bone marrow function: Acute leukaemia, myelodysplasia, myeloma Infiltration with lymphoma, solid tumours, tuberculosis Megaloblastic anaemia Paroxysmal nocturnal haemoglobinuria Myelofibrosis Haemophagocytic syndrome Increased peripheral destruction: Splenomegaly(hypersplenism)

Diagnosis: The disease must be distinguished from other causes of pancytopenia and this is not usually difficult provided _an adequate bone marrow sample is obtained. _Cytogenetic analysis should be performed. _Paroxysmal nocturnal haemoglobinuria (PNH) must be excluded by flow-cytometry testing of red cells for CD55 and CD59. In older patients,hypoplastic myelodysplasia may show similar appearances. Qualitative abnormalities of the cells and clonal cytogenetic changes suggest myelodysplasia rather than aplastic anaemia. Some patients diagnosed as having aplastic anaemia develop PNH, myelodysplasia or acute myeloid leukaemia in subsequent years.

Red cell aplasia: 1. Acute, transient: a_parvovirus B19 infects red cell precursors and causes a transient (5-10 days) red cell aplasia with the rapid onset of severe anaemia in patients with pre-existing shortened red cell survival (e.g. sickle cell disease or hereditary spherocytosis); b_transient red cell aplasia with anaemia may also occur in association with drug therapy (e.g. azathioprine, cotrimoxazole), c_and in normal infants or children, often with a history of a viral infection in the preceding 3 months.

2. Chronic form:this is a syndrome characterized by anaemia with normal leucocytes and platelets and reduced or absent erythroblasts in the marrow. The congenital form is known as: Diamond-Blackfan syndrome : _It is inherited as a recessive condition. _associated with a varying number of somatic disorders (e.g. of the face or heart). _The median age at presentation is 8 weeks and 93% of patients presented in the first year of life. _Mutation of a gene on chromosome 19 that encodes a ribosomal protein underlies some cases.

The acquired chronic form: _ can occur without any obvious associated disease or precipitating factor (idiopathic). _may be seen with autoimmune diseases (especially systemic lupus erythematosus),with a thymoma, lymphoma or chronic lymphocytic leukaemia. _Red cell aplasia from anti-erythropoietin antibodies has been rarely described in patients with chronic renal failure receiving recombinant erythropoietin.

selective loss of erythropoiesis

Congenital dyserythropoietic anaemia: a group of hereditary refractory anaemias characterized by: _ ineffective erythropoiesis. _internuclear bridging in normoblasts, erythroblast multinuclearity and Giant multinucleated erythroblast. _The patient may be jaundiced with bone marrow expansion. _ The white cell and platelet counts are normal. _ The reticulocyte count is low for the degree of anaemia, despite increased marrow cellularity. The anaemia is of variable severity and is usually first noted in infancy or childhood.

multinuclearity. internuclear bridging in normoblasts Giant multinucleated erythroblast

Thank you